Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition

L. N. Hockey, B. S. Kilpatrick, Emily R. Eden, Yaping Lin-Moshier, G. Cristina Brailoiu, Eugen Brailoiu, Clare E. Futter, Anthony H. Schapira, Jonathan S. Marchant, Sandip Patel

Research output: Contribution to journalArticlepeer-review

141 Scopus citations


Two-pore channels (TPCs) are endolysosomal ion channels implicated in Ca2+ signalling from acidic organelles. The relevance of these ubiquitous proteins for human disease, however, is unclear. Here, we report that lysosomes are enlarged and aggregated in fibroblasts from Parkinson disease patients with the common G2019S mutation in LRRK2. Defects were corrected by molecular silencing of TPC2, pharmacological inhibition of TPC regulators [Rab7, NAADP and PtdIns(3,5)P2] and buffering local Ca2+ increases. NAADP-evoked Ca2+ signals were exaggerated in diseased cells. TPC2 is thus a potential drug target within a pathogenic LRRK2 cascade that disrupts Ca2+-dependent trafficking in Parkinson disease.

Original languageEnglish (US)
Pages (from-to)232-238
Number of pages7
JournalJournal of cell science
Issue number2
StatePublished - 2015

Bibliographical note

Publisher Copyright:
© 2015. Published by The Company of Biologists Ltd.


  • Ca
  • LRRK2
  • Lysosomes
  • Parkinson disease
  • TPCN2


Dive into the research topics of 'Dysregulation of lysosomal morphology by pathogenic LRRK2 is corrected by TPC2 inhibition'. Together they form a unique fingerprint.

Cite this